HSBC maintains buy on AbbVie, raises target to $315
Benzinga/TradingView reports that HSBC raised its AbbVie price target to $315 from $300 and maintained a Buy rating.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.